Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders

Psychedelics, a class of hallucinogenic drugs, have been explored for treatment-resistant psychiatric illnesses. Recent clinical studies report marked improvements in mental health from psilocybin-assisted psychotherapy, with safety and efficacy as primary objectives. Evidence suggests psilocybin is safe in controlled environments and a valid therapeutic alternative to other psychiatric medications, but further research is needed to determine its efficacy and safety for potential medical applications.

Study at a glance

Abstract

Psychedelics are a class of hallucinogenic drugs. They have been explored particularly for treatment-resistant psychiatric illnesses. In recent years, advances in psychopharmacology have benefited thousands of patients with some type of mental disorder. Preliminary evidence has shown that psilocybin has shown promise in the treatment of psychiatric disorders, with the support of qualified doctors. Recent clinical studies have reported marked improvements in mental health in psilocybinassisted psychotherapy. In many studies, the safety and efficacy of psilocybin have been the primary objectives to show that it is a safe and valid therapeutic alternative to other forms of psychiatric medications. Currently, some studies prove that psilocybin is safe in a controlled environment. However, the use of psilocybin needs to be further studied to determine the efficacy and safety of potential applications in medicine.